1040 related articles for article (PubMed ID: 29776961)
41. Differences in Short- and Long-Term Outcomes Among Older Patients With ST-Elevation Versus Non-ST-Elevation Myocardial Infarction With Angiographically Proven Coronary Artery Disease.
Vora AN; Wang TY; Hellkamp AS; Thomas L; Henry TD; Goyal A; Roe MT
Circ Cardiovasc Qual Outcomes; 2016 Sep; 9(5):513-22. PubMed ID: 27601458
[TBL] [Abstract][Full Text] [Related]
42. Prognostic efficacy of C-reactive protein/albumin ratio in ST elevation myocardial infarction.
Çınar T; Çağdaş M; Rencüzoğulları İ; Karakoyun S; Karabağ Y; Yesin M; Sadioğlu Çağdaş Ö; Tanboğa Hİ
Scand Cardiovasc J; 2019 Apr; 53(2):83-90. PubMed ID: 30835559
[TBL] [Abstract][Full Text] [Related]
43. ST-segment elevation on intracoronary electrocardiogram after percutaneous coronary intervention is associated with worse outcome in patients with non-ST-segment elevation myocardial infarction.
Hishikari K; Kakuta T; Lee T; Murai T; Yonetsu T; Isobe M
Catheter Cardiovasc Interv; 2016 Mar; 87(4):E113-21. PubMed ID: 26152334
[TBL] [Abstract][Full Text] [Related]
44. Admission Bedside Lung Ultrasound Reclassifies Mortality Prediction in Patients With ST-Segment-Elevation Myocardial Infarction.
Araujo GN; Silveira AD; Scolari FL; Custodio JL; Marques FP; Beltrame R; Menegazzo W; Machado GP; Fuchs FC; Goncalves SC; Wainstein RV; Leiria TL; Wainstein MV
Circ Cardiovasc Imaging; 2020 Jun; 13(6):e010269. PubMed ID: 32536197
[TBL] [Abstract][Full Text] [Related]
45. Cardiovascular Mortality in Chest Pain Patients: Comparison of Natriuretic Peptides With Novel Biomarkers of Cardiovascular Stress.
Sinning C; Ojeda F; Zeller T; Zengin E; Rupprecht HJ; Lackner KJ; Bickel C; Blankenberg S; Schnabel RB; Westermann D
Can J Cardiol; 2016 Dec; 32(12):1470-1477. PubMed ID: 27568502
[TBL] [Abstract][Full Text] [Related]
46. Benefit From Reperfusion With Primary Percutaneous Coronary Intervention Beyond 12 Hours of Symptom Duration in Patients With ST-Segment-Elevation Myocardial Infarction.
Nepper-Christensen L; Lønborg J; Høfsten DE; Ahtarovski KA; Bang LE; Helqvist S; Kyhl K; Køber L; Kelbæk H; Vejlstrup N; Holmvang L; Engstrøm T
Circ Cardiovasc Interv; 2018 Sep; 11(9):e006842. PubMed ID: 30354595
[TBL] [Abstract][Full Text] [Related]
47. Midregional fragment of proadrenomedullin, new-onset albuminuria, and cardiovascular and all-cause mortality in patients with type 2 diabetes (ZODIAC-30).
Landman GW; van Dijk PR; Drion I; van Hateren KJ; Struck J; Groenier KH; Gans RO; Bilo HJ; Bakker SJ; Kleefstra N
Diabetes Care; 2014; 37(3):839-45. PubMed ID: 24170764
[TBL] [Abstract][Full Text] [Related]
48. Prognostic potential of midregional pro-adrenomedullin following decompensation for systolic heart failure: comparison with cardiac natriuretic peptides.
Morbach C; Marx A; Kaspar M; Güder G; Brenner S; Feldmann C; Störk S; Vollert JO; Ertl G; Angermann CE;
Eur J Heart Fail; 2017 Sep; 19(9):1166-1175. PubMed ID: 28516504
[TBL] [Abstract][Full Text] [Related]
49. Biomarkers and clinical scores to identify patient populations at risk of delayed antibiotic administration or intensive care admission.
Gonzalez Del Castillo J; Wilson DC; Clemente-Callejo C; Román F; Bardés-Robles I; Jiménez I; Orviz E; Dastis-Arias M; Espinosa B; Tornero-Romero F; Giol-Amich J; González V; Llopis-Roca F;
Crit Care; 2019 Oct; 23(1):335. PubMed ID: 31665092
[TBL] [Abstract][Full Text] [Related]
50. Midregional proadrenomedullin and growth differentiation factor-15 are not influenced by obesity in heart failure patients.
Sinning C; Ojeda F; Wild PS; Schnabel RB; Schwarzl M; Ohdah S; Lackner KJ; Pfeiffer N; Michal M; Blettner M; Munzel T; Kempf T; Wollert KC; Kuulasmaa K; Blankenberg S; Salomaa V; Westermann D; Zeller T
Clin Res Cardiol; 2017 Jun; 106(6):401-410. PubMed ID: 28004184
[TBL] [Abstract][Full Text] [Related]
51. Relationship Between Troponin on Presentation and In-Hospital Mortality in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
Wanamaker BL; Seth MM; Sukul D; Dixon SR; Bhatt DL; Madder RD; Rumsfeld JS; Gurm HS
J Am Heart Assoc; 2019 Oct; 8(19):e013551. PubMed ID: 31547767
[TBL] [Abstract][Full Text] [Related]
52. Correlates and prognostic impact of new-onset heart failure after ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: insights from the INFUSE-AMI trial.
Giustino G; Redfors B; Brener SJ; Kirtane AJ; Généreux P; Maehara A; Dudek D; Neunteufl T; Metzger DC; Crowley A; Mehran R; Gibson CM; Stone GW
Eur Heart J Acute Cardiovasc Care; 2018 Jun; 7(4):339-347. PubMed ID: 28828881
[TBL] [Abstract][Full Text] [Related]
53. Angiographically Guided Complete Revascularization Versus Selective Stress Echocardiography-Guided Revascularization in Patients With ST-Segment-Elevation Myocardial Infarction and Multivessel Disease: The CROSS-AMI Randomized Clinical Trial.
Calviño-Santos R; Estévez-Loureiro R; Peteiro-Vázquez J; Salgado-Fernández J; Rodríguez-Vilela A; Franco-Gutiérrez R; Bouzas-Mosquera A; Rodríguez-Fernández JÁ; Mesías-Prego A; González-Juanatey C; Aldama-López G; Piñón-Esteban P; Flores-Ríos X; Soler-Martín R; Seoane-Pillado T; Vázquez-González N; Muñiz J; Vázquez-Rodríguez JM
Circ Cardiovasc Interv; 2019 Oct; 12(10):e007924. PubMed ID: 31554422
[TBL] [Abstract][Full Text] [Related]
54. Pro-Adrenomedullin predicts 10-year all-cause mortality in community-dwelling patients: a prospective cohort study.
Odermatt J; Meili M; Hersberger L; Bolliger R; Christ-Crain M; Briel M; Bucher HC; Mueller B; Schuetz P
BMC Cardiovasc Disord; 2017 Jul; 17(1):178. PubMed ID: 28676115
[TBL] [Abstract][Full Text] [Related]
55. Prognostic value of cardiac time intervals by tissue Doppler imaging M-mode in patients with acute ST-segment-elevation myocardial infarction treated with primary percutaneous coronary intervention.
Biering-Sørensen T; Mogelvang R; Søgaard P; Pedersen SH; Galatius S; Jørgensen PG; Jensen JS
Circ Cardiovasc Imaging; 2013 May; 6(3):457-65. PubMed ID: 23536267
[TBL] [Abstract][Full Text] [Related]
56. MR-proANP and MR-proADM for risk stratification of patients with acute chest pain.
Tzikas S; Keller T; Ojeda FM; Zeller T; Wild PS; Lubos E; Kunde J; Baldus S; Bickel C; Lackner KJ; Münzel TF; Blankenberg S
Heart; 2013 Mar; 99(6):388-95. PubMed ID: 23213173
[TBL] [Abstract][Full Text] [Related]
57. Prognostic implications of Q waves at presentation in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: An analysis of the HORIZONS-AMI study.
Kosmidou I; Redfors B; Crowley A; Gersh B; Chen S; Dizon JM; Embacher M; Mehran R; Ben-Yehuda O; Mintz GS; Stone GW
Clin Cardiol; 2017 Nov; 40(11):982-987. PubMed ID: 28696573
[TBL] [Abstract][Full Text] [Related]
58. Time to treatment and three-year mortality after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction-a DANish Trial in Acute Myocardial Infarction-2 (DANAMI-2) substudy.
Maeng M; Nielsen PH; Busk M; Mortensen LS; Kristensen SD; Nielsen TT; Andersen HR;
Am J Cardiol; 2010 Jun; 105(11):1528-34. PubMed ID: 20494656
[TBL] [Abstract][Full Text] [Related]
59. Mid-regional pro-adrenomedullin: an indicator of the failing Fontan circuit in patients with univentricular hearts?
Kaiser R; Abdul-Khaliq H; Wilkens H; Herrmann E; Raedle-Hurst TM
Eur J Heart Fail; 2014 Oct; 16(10):1082-8. PubMed ID: 25201135
[TBL] [Abstract][Full Text] [Related]
60. Relation of Low-Density Lipoprotein Cholesterol With Microvascular Injury and Clinical Outcome in Revascularized ST-Elevation Myocardial Infarction.
Reindl M; Reinstadler SJ; Feistritzer HJ; Theurl M; Basic D; Eigler C; Holzknecht M; Mair J; Mayr A; Klug G; Metzler B
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29018020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
